How to choose a BPC-157 provider

What BPC-157 is, factually

BPC-157 is a synthetic peptide made of 15 amino acids. Its sequence is a fragment of a larger protein found in human gastric juice — the “BPC” stands for body protection compound, the name researchers gave that parent protein. It has been studied in research settings since the 1990s, and it is not an FDA-approved drug.

That is a deliberately short description. What BPC-157 might mean for you is a question for a licensed clinician who has reviewed your labs and medical history — not for a marketing page, ours included. What we can cover here, in detail, is the part almost nobody explains well: how to tell legitimate medical sourcing from the unregulated market that has grown up around this peptide.

One more piece of context worth having: in the US, the list of substances that licensed pharmacies may compound changes as FDA policy is updated. In early 2026, HHS announced that a group of peptides would move back toward eligibility for pharmacy compounding, and the FDA’s Pharmacy Compounding Advisory Committee took up review of which bulk substances licensed 503A pharmacies may use. A provider operating inside the regulated system tracks this and adjusts its catalog when policy changes. A research-chemical seller never has to, because it was never operating inside the system to begin with.

Why sourcing matters for this substance in particular

For years, BPC-157 has circulated online as a “research chemical”: vials sold without a prescription, labeled “for research use only,” and shipped to anyone with a credit card. Those labels are not a formality. They mean the product is explicitly not intended for human use, no clinician evaluated the buyer, no pharmacy dispensed it, and no licensed professional is accountable for what the vial contains.

The practical consequence is simple: with a research-grade product, the identity, purity, and sterility of what you receive cannot be verified by you or anyone else. There is no dispensing record, no batch accountability, and no license on the line. For a substance that is typically administered by injection, sterility is not a paperwork detail — it is the whole reason pharmacy regulation exists.

None of this requires fear to state. It is just the difference between a regulated supply chain and an unregulated one. A legitimate route exists in the US: a licensed clinician evaluates you, decides at their discretion whether to prescribe, and a licensed compounding pharmacy prepares and dispenses the medication under state and federal pharmacy rules. Our guide to licensed clinics vs. research-grade peptide sellers covers that divide in depth.

What a legitimate process looks like, end to end

Whoever the provider is, the shape of a real process is recognizable. It has five parts:

1. 1

   A medical intake. You answer real questions about your health history, current medications, and anything that would make a prescription inappropriate. This takes more than a minute.

2. 2

   Objective data. Bloodwork, recent labs, or medical records give the clinician something concrete to evaluate — not just your answers to a form.

3. 3

   A licensed clinician’s review. A named, licensed clinician reviews your intake and labs and decides whether a prescription is appropriate. Prescribing is always at the clinician’s discretion — which means a legitimate process can end in “no.” A provider that can never say no is not running an evaluation.

4. 4

   Dispensing by a licensed pharmacy. The prescription is filled by an identifiable, licensed US pharmacy — for compounded peptides, typically a 503A compounding pharmacy preparing medication against your individual prescription. You should be told which pharmacy, and you should be able to verify its license with the state board of pharmacy.

5. 5

   Care that continues after checkout. A way to reach the clinical team with questions, and scheduled follow-up. Medicine does not end when the package ships.

Seven questions to ask any BPC-157 provider

You can ask every one of these before spending a dollar. A legitimate provider will answer all seven without hesitation — the answers are the basics of how they operate.

1. 1

   Who would prescribe this, and where are they licensed?

   A real provider can tell you who its clinicians are and in which states they hold licenses. State medical boards have public lookup tools — a license you can verify in minutes is the baseline, not a bonus.

2. 2

   What does the evaluation actually involve?

   Ask what the clinician reviews before deciding. If the answer includes a medical intake and labs or records, that’s an evaluation. If the answer is a short form between you and a checkout page, it isn’t.

3. 3

   Can the evaluation end in a no?

   Ask directly whether some applicants are declined. Prescribing at a clinician’s discretion means the answer must be yes. A provider that approves everyone is selling a product, not practicing medicine.

4. 4

   Which pharmacy dispenses the medication?

   You should get a name — an identifiable, licensed US pharmacy whose license you can check with the state board of pharmacy. “Our pharmacy partner” with no name attached is not an answer.

5. 5

   Is it compounded per prescription by a 503A pharmacy?

   503A compounding pharmacies prepare medication against individual prescriptions under state board oversight. Ask whether that’s how your medication would be prepared, and under what oversight.

6. 6

   Is each batch independently tested?

   Ask whether preparations are tested by an independent laboratory and whether documentation exists for your batch. A provider with a real pharmacy chain behind it can answer this specifically.

7. 7

   Who do I talk to after I start?

   Ask how follow-up works: how you reach the clinical team, whether consults are included, and who answers questions once the medication has shipped. If the relationship ends at delivery, it was retail, not care.

How Meto approaches each point

We built Meto to pass this exact checklist, so the short version is easy to give. Two clinician-prescribed Meto protocols include BPC-157 — one at $175–225/mo (protocol details) and one at $249–349/mo, paired with TB-500 (protocol details). Which protocol — if any — is appropriate for you is a clinical decision, not a menu choice.

If you are comparing providers more broadly, our comparison hub collects the pricing pages, provider comparisons, and vetting guides in one place — including this checklist, which works on us as well as on anyone else.

The five-minute version of this whole guide: a prescriber whose license you can verify, an evaluation that can end in a no, a dispensing pharmacy with a name, independent batch testing, and a clinical team you can still reach after the box arrives. Any provider that clears four of five is worth a conversation. Any provider that clears none of them is not a provider.